NCT07625644 2026-06-04Evaluate BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung CancerSystImmune Inc.Phase 3 Not yet recruiting550 enrolled
NCT03609047 2026-05-12AppalachesEuropean Organisation for Research and Treatment of Cancer - EORTCPhase 2 Active not recruiting366 enrolled